Eye Care in Belgium

Abstract
Eye care was expected to return to a positive performance in 2022 following declines in 2021 and, particularly, 2020, but this does not seem to be the case. The return to more normal lifestyles after the pandemic did not result in a resurgence of sales due to the strong dependence on consultations in this category. Belgian consumers remain reluctant to use any new substances or solutions for their eyes without first receiving professional advice or a prescription from their ophthalmologist. Once...

Euromonitor International's Eye Care in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

Product coverage: Allergy Eye Care, Standard Eye Care.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Eye Care market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Content
Eye Care in Belgium

List Of Contents And Tables

EYE CARE IN BELGIUM
KEY DATA FINDINGS
2022 DEVELOPMENTS
No real improvement in eye care in 2022 due to ongoing delays for ophthalmologist appointments
Eye care stays afloat thanks to the ongoing home-working trend and the progression of allergies
GSK’s Terramycin is top brand but Théa Pharma maintains its company lead in a fiercely competitive landscape
PROSPECTS AND OPPORTUNITIES
Despite the ageing of the population, category faces challenge of short lifecycles, cannibalisation and lack of investment
Uncertain progression of self-medication
Ophthalmologists remain essential for the promotion of eye care
CATEGORY DATA
Table 1 Sales of Eye Care by Category: Value 2017-2022
Table 2 Sales of Eye Care by Category: % Value Growth 2017-2022
Table 3 NBO Company Shares of Eye Care: % Value 2018-2022
Table 4 LBN Brand Shares of Eye Care: % Value 2019-2022
Table 5 Forecast Sales of Eye Care by Category: Value 2022-2027
Table 6 Forecast Sales of Eye Care by Category: % Value Growth 2022-2027
CONSUMER HEALTH IN BELGIUM
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 8 Life Expectancy at Birth 2017-2022
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2017-2022
Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
Table 14 Distribution of Consumer Health by Format: % Value 2017-2022
Table 15 Distribution of Consumer Health by Format and Category: % Value 2022
Table 16 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources